SOCS2 and acute myeloid leukemia: SOCS2 was selected because it resulted as the top gene from the survival modeling approach; in addition, it was strongly and significantly up-regulated at relapse of AML, a disease stage that is often refractory to therapy and thus can be considered as inherently aggressive38.